Company: SRPT
Filing Date: 2025-03-03
Form Type: S-3ASR
Source: 0001193125-25-044088
Chunk: 34

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-03-03
Form: S-3ASR
Chunk 34
---
 |        |     |      |            |     |         |     |     |        |          |     |          | X |
| 23.1    |     | Consent of KPMG LLP, independent registered public accounting firm                                              |     |                                      |        |     |      |            |     |         |     |     |        |          |     |          | X |
| 23.2    |     | Consent of Ropes & Gray LLP (included in Exhibit 5.1)                                                           |     |                                      |        |     |      |            |     |         |     |     |        |          |     |          | X |
| 24.1    |     | Power of Attorney (contained on signature page)                                                                 |     |                                      |        |     |      |            |     |         |     |     |        |          |     |          | X |
| 25.1    |     | Form T-1 Statement of Eligibility of Trustee for Subordinated Indenture under the Trust Indenture Act of 1939*  |     |                                      |        |     |      |            |     |         |     |     |        |          |     |          |   |
| 107     |     | Filing Fee Table                                                                                                |     |                                      |        |     |      |            |     |         |     |     |        |          |     |          | X |

| * | To be filed by amendment or as an exhibit to a report pursuant to Section 13(a) or 15(d) of the Securities 
 Exchange Act of 1934, as amended, and incorporated herein by reference.                                    |

II-2

Item 17. Undertakings.

The undersigned registrant hereby undertakes:

1. To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from